New York State Common Retirement Fund Nektar Therapeutics Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Nektar Therapeutics stock. As of the latest transaction made, New York State Common Retirement Fund holds 18,800 shares of NKTR stock, worth $17,484. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,800
Previous 87,800
78.59%
Holding current value
$17,484
Previous $109,000
77.98%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding NKTR
# of Institutions
145Shares Held
139MCall Options Held
32.6KPut Options Held
14.1K-
Deep Track Capital, LP Greenwich, CT15.9MShares$14.8 Million0.76% of portfolio
-
Black Rock Inc. New York, NY15.2MShares$14.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$12.2 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA9.4MShares$8.74 Million0.22% of portfolio
-
Samlyn Capital, LLC New York, NY9.2MShares$8.56 Million0.19% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $174M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...